The US trade name for rimonabant, which the WSJ says “seems to promise a mysterious Italian delicacy — ‘We’d like the Zimulti with clams, please.'”
Accomplia Zimulti
ADVERTISEMENT
More in Uncategorized
Past Week
-
Retirement isn’t the end of medicine, it’s a second act [PODCAST]
-
The conflict of interest that discloses as nothing
-
Chronic inflammation and immune aging may share mechanisms
-
What clinical support staff notice that charts never show
-
Digital noise in health care is fragmenting clinical focus
-
How to diagnose supplement toxicity in 4 clinical steps
-
Past 6 Months
-
Why CDC opioid guidelines get the overdose data wrong
-
Retirement isn’t the end of medicine, it’s a second act [PODCAST]
-
Sensory processing in autism and the brain’s volume control
-
What maternity care deserts cost a town
-
Why medicine needs a national physician license now
-
A cold cost $945. The cost of primary care is broken.
-
Recent Posts
-
Digital noise in health care is fragmenting clinical focus
-
Moral agency in medicine is being squeezed by payer audits
-
Why choose sleep medicine as an intellectual frontier
-
After 2 failed antidepressants, raise TMS and esketamine
-
An AI pain study says models would delete your photos
-
Food allergies are treated differently, airline by airline [PODCAST]
-
Subscribe to KevinMD and never miss a story!
Get free updates delivered free to your inbox.
